Mechanism of Eukaryotic Translation Termination

真核翻译终止机制

基本信息

  • 批准号:
    7067093
  • 负责人:
  • 金额:
    $ 27.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-06-01 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In eukaryotic organisms, eRF1 recognizes the three translation termination codons and mediates the release of nascent polypeptide chains. The accessory factor eRF3 assists the termination process in a GTP-dependent manner. Over the last few years, our understanding of how eRF1 recognizes stop codons and facilitates polypeptide chain release has increased, but much work remains to be done. In contrast, little has been done to understand how GTP hydrolysis by eRF3 assists in the termination process. Unlike prokaryotes, eRF3 is an essential gene in yeast. Furthermore, eRF3 has been shown to interact not only with eRF1, but also with other proteins involved in various aspects of mRNA function and metabolism, including poly(A)-binding protein and Upflp, Upf2p, and Upf3p. This suggests that eRF3 may act not only in translation termination, but also couple the termination process to other related cellular functions such as mRNA stability, NMD, and possibly translation initiation. To better understand how eRF1 and eRF3 function in translation termination, we propose the following Specific Aims: Specific Aim 1): Determine the function of eRF3 in translation termination. We will couple a mutational analysis of eRF3 to in vitro and in vivo functional assays to determine the role of eRF3 in this process. Specific Aim 2): Determine how eRF1 and the ribosome influence eRF3 function in translation termination. We will use functional assays to determine how these factors stimulate the GTPase activity of eRF3. Specific Aim 3): Determine whether phosphorylation and/or methylation of eRF1 modulates its function during translation termination. We will use mass spectrometry to characterize the post-translational modification of eRF1. We will then examine how phosphorylation influences eRF1 function, and determine whether the highly conserved GGQ motif is methylated in eukaryotes. Specific Aim 4): Determine how two new factors, Pst21p and Slhlp, influence the efficiency of translation termination. We will examine whether these factors interact directly with eRF1, eRF3, or Upflp, and examine functional motifs in these proteins that may provide clues to their cellular function.
DESCRIPTION (provided by applicant): In eukaryotic organisms, eRF1 recognizes the three translation termination codons and mediates the release of nascent polypeptide chains. The accessory factor eRF3 assists the termination process in a GTP-dependent manner. Over the last few years, our understanding of how eRF1 recognizes stop codons and facilitates polypeptide chain release has increased, but much work remains to be done. In contrast, little has been done to understand how GTP hydrolysis by eRF3 assists in the termination process. Unlike prokaryotes, eRF3 is an essential gene in yeast. Furthermore, eRF3 has been shown to interact not only with eRF1, but also with other proteins involved in various aspects of mRNA function and metabolism, including poly(A)-binding protein and Upflp, Upf2p, and Upf3p. This suggests that eRF3 may act not only in translation termination, but also couple the termination process to other related cellular functions such as mRNA stability, NMD, and possibly translation initiation. To better understand how eRF1 and eRF3 function in translation termination, we propose the following Specific Aims: Specific Aim 1): Determine the function of eRF3 in translation termination. We will couple a mutational analysis of eRF3 to in vitro and in vivo functional assays to determine the role of eRF3 in this process. Specific Aim 2): Determine how eRF1 and the ribosome influence eRF3 function in translation termination. We will use functional assays to determine how these factors stimulate the GTPase activity of eRF3. Specific Aim 3): Determine whether phosphorylation and/or methylation of eRF1 modulates its function during translation termination. We will use mass spectrometry to characterize the post-translational modification of eRF1. We will then examine how phosphorylation influences eRF1 function, and determine whether the highly conserved GGQ motif is methylated in eukaryotes. Specific Aim 4): Determine how two new factors, Pst21p and Slhlp, influence the efficiency of translation termination. We will examine whether these factors interact directly with eRF1, eRF3, or Upflp, and examine functional motifs in these proteins that may provide clues to their cellular function.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David M. Bedwell其他文献

Long-term nonsense suppression therapy with NB84 moderates MPS IH disease progression
  • DOI:
    10.1016/j.ymgme.2013.12.106
  • 发表时间:
    2014-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Gwendolyn G. Gunn;Yanying Dai;Ming Du;Valery Beklakhov;Jeyakumar Kandasamy;Trenton R. Schoeb;Timor Baasov;David M. Bedwell;Kim M. Keeling
  • 通讯作者:
    Kim M. Keeling
The nonsense suppression drug PTC124 restored alpha-<span class="small-caps">l</span>-iduronidase activity and reduces glycosaminoglycan accumulation in MPS IH mice carrying the Idua-W402X mutation
  • DOI:
    10.1016/j.ymgme.2014.12.026
  • 发表时间:
    2015-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    David M. Bedwell;Dan Wang;Ellen M. Welch;Kim M. Keeling
  • 通讯作者:
    Kim M. Keeling

David M. Bedwell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David M. Bedwell', 18)}}的其他基金

New Nonsense Suppression Drugs to Treat MPS I
治疗 MPS I 的新型无意义抑制药物
  • 批准号:
    8842247
  • 财政年份:
    2014
  • 资助金额:
    $ 27.4万
  • 项目类别:
Mechanism of Eukaryotic Translation Termination
真核翻译终止机制
  • 批准号:
    7997463
  • 财政年份:
    2009
  • 资助金额:
    $ 27.4万
  • 项目类别:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
MPS I-H 小鼠 Idua-W402X 突变的抑制
  • 批准号:
    7340377
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:
UAB CFRC Administrative Core
UAB CFRC 行政核心
  • 批准号:
    10673354
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
MPS I-H 小鼠 Idua-W402X 突变的抑制
  • 批准号:
    8015606
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:
UAB CF Research and Translation Core Center
UAB CF 研究与翻译核心中心
  • 批准号:
    10673353
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
MPS I-H 小鼠 Idua-W402X 突变的抑制
  • 批准号:
    7179609
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:
Animal Models Core
动物模型核心
  • 批准号:
    8320678
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
MPS I-H 小鼠 Idua-W402X 突变的抑制
  • 批准号:
    7560341
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:
UAB CF Research and Translation Core Center
UAB CF 研究与翻译核心中心
  • 批准号:
    10468801
  • 财政年份:
    2007
  • 资助金额:
    $ 27.4万
  • 项目类别:

相似海外基金

Development of a highly integrated circuit using DNA and a demonstration test of the parallel computation using a complementary DNA as an operator
使用DNA的高度集成电路的开发以及使用互补DNA作为算子的并行计算的演示测试
  • 批准号:
    17K06395
  • 财政年份:
    2017
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pseudo-Complementary DNA
伪互补DNA
  • 批准号:
    8072639
  • 财政年份:
    2010
  • 资助金额:
    $ 27.4万
  • 项目类别:
Pseudo-Complementary DNA
伪互补DNA
  • 批准号:
    7871949
  • 财政年份:
    2010
  • 资助金额:
    $ 27.4万
  • 项目类别:
Quantitative analysis in neurotrophic factor genes of spinal cord with complementary DNA microarray
互补DNA微阵列定量分析脊髓神经营养因子基因
  • 批准号:
    18390411
  • 财政年份:
    2006
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of gene expression following maxillofacial inflammation in rat using complementary DNA microarray
使用互补 DNA 微阵列分析大鼠颌面部炎症后的基因表达
  • 批准号:
    15390628
  • 财政年份:
    2003
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Complementary DNA cloning and characterization of rat spergen-3,a spermatogenic cell-specific gene-3,expressed in mammalian spermatogenic cells
大鼠 spergen-3(生精细胞特异性基因 3,在哺乳动物生精细胞中表达)的互补 DNA 克隆和表征
  • 批准号:
    15570179
  • 财政年份:
    2003
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Microbial Genome Sequencing: Gene Discovery and Mapping Tools for Ichthyophthirius: A Complementary DNA Resource
微生物基因组测序:鱼霉属基因发现和作图工具:补充 DNA 资源
  • 批准号:
    0333246
  • 财政年份:
    2003
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Continuing Grant
GENE EXPRESSION ANALYSIS OF THE SPINAL CORD UNDER CHRONIC MECHANICAL COMPRESSION USING IN-HOUSE COMPLEMENTARY DNA MICROARRAY
使用内部互补 DNA 微阵列对慢性机械压迫下的脊髓进行基因表达分析
  • 批准号:
    15591563
  • 财政年份:
    2003
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of antisense vascular endothelial growth factor complementary DNA on the growth of human glioma cells.
反义血管内皮生长因子互补DNA对人胶质瘤细胞生长的影响。
  • 批准号:
    07671538
  • 财政年份:
    1995
  • 资助金额:
    $ 27.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DENATURATION OF SELF-COMPLEMENTARY DNA LOOPS
自互补 DNA 环的变性
  • 批准号:
    3466758
  • 财政年份:
    1988
  • 资助金额:
    $ 27.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了